U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia (Q34157931)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia |
scientific article |
Statements
1 reference
U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia (English)
1 reference
Sandra J Casak
1 reference
Steven J Lemery
1 reference
Yuan Li Shen
1 reference
Mark D Rothmann
1 reference
Aakanksha Khandelwal
1 reference
Hong Zhao
1 reference
Gina Davis
1 reference
Vaishali Jarral
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
6 January 2011
1 reference
1 reference
16
1 reference
97-104
1 reference
Identifiers
1 reference
1 reference
1 reference